Reading brain scans for immune clues in lung cancer that spread to the brain
Original title: Impact of a Radiologic and Immunologic Signature on Cerebral Efficacy of Treatments in Lung Cancers With Brain Metastasis
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
No phase is listed for this study, and it is still research, not care you can get.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study asks if brain scan details can show how the immune system is acting inside a brain tumor.
Who this trial is for. This study is for people with non-small cell lung cancer that has spread to the brain. It looks back at brain MRI scans and at tumor tissue, to see if scan details line up with immune signs in the tumor.
Where it stands. This study has not reported results. Researchers are measuring whether MRI scan details match the immune makeup of brain tumors. They also want to see if those details can help predict brain tumor growth during immunotherapy. The answer is not in yet.
What this means, and what it doesn't
What it could mean: If the idea pans out, a scan might one day give doctors immune clues without taking a tissue sample. That is a hope, not a result. Someone who thinks they fit can ask their care team about it.
What it doesn't mean: This does not mean there is a new treatment. A trial is a test, not proven care. Taking part is not a promise that it will help you. And this is not a cure.
Source: ClinicalTrials.gov, October 29, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.